A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib

Clinical trial NCT04253223 · TERMINATED

Trial details

NCT number: NCT04253223
Sponsor: Duke University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hyperglycemia Drug Induced

Start date: 2020-04-07
Primary completion: 2021-05-05
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.